Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Issue 8 (21st March 2022) - Fangusaro, Jason R; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal Ian; Banerjee, Anuradha; Packer, Roger; Kilburn, Lindsay B; Pollack, Ian F; Qaddoumi, Ibrahim A; Fisher, Paul Graham; et al.